205 related articles for article (PubMed ID: 38899764)
1. The gut-immune axis during hypertension and cardiovascular diseases.
Dinakis E; O'Donnell JA; Marques FZ
Acta Physiol (Oxf); 2024 Jun; ():e14193. PubMed ID: 38899764
[TBL] [Abstract][Full Text] [Related]
2. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
3. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiome and Cardiovascular Disease.
Astudillo AA; Mayrovitz HN
Cureus; 2021 Apr; 13(4):e14519. PubMed ID: 34007770
[TBL] [Abstract][Full Text] [Related]
5. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
Suganya K; Son T; Kim KW; Koo BS
Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
9. Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis-A Potential Therapeutic Intervention to Improve Lung Health.
Verma A; Bhagchandani T; Rai A; Nikita ; Sardarni UK; Bhavesh NS; Gulati S; Malik R; Tandon R
ACS Omega; 2024 Apr; 9(13):14648-14671. PubMed ID: 38585101
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
11. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
13. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
Jama HA; Beale A; Shihata WA; Marques FZ
Cardiovasc Res; 2019 Jul; 115(9):1435-1447. PubMed ID: 30951169
[TBL] [Abstract][Full Text] [Related]
14. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
[TBL] [Abstract][Full Text] [Related]
15. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
Zhu J; Lyu J; Zhao R; Liu G; Wang S
Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and myocardial fibrosis.
Xu H; Yang F; Bao Z
Eur J Pharmacol; 2023 Feb; 940():175355. PubMed ID: 36309048
[TBL] [Abstract][Full Text] [Related]
18. Microbiome interactions with different risk factors in development of myocardial infarction.
Bijla M; Saini SK; Pathak AK; Bharadwaj KP; Sukhavasi K; Patil A; Saini D; Yadav R; Singh S; Leeuwenburgh C; Kumar P
Exp Gerontol; 2024 May; 189():112409. PubMed ID: 38522483
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]